A public health perspective on CKD and obesity

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.4, 2013, Pages

  McClellan, William M ^a,b   Plantinga, Laura C ^a,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

CKD; Obesity; Public health; Translational research

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SURVEILLANCE; END STAGE RENAL DISEASE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HEALTH CARE POLICY; HEALTH PROGRAM; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MORTALITY; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PUBLIC HEALTH; REVIEW; WEIGHT REDUCTION;

CKD; OBESITY; PUBLIC HEALTH; TRANSLATIONAL RESEARCH;

ANIMALS; HUMANS; OBESITY; PUBLIC HEALTH; RENAL INSUFFICIENCY, CHRONIC;

EID: 84890057730     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft030     Document Type: Review

References (68)

1. McCullough K, Sharma P, Ali T et al. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant 2012; 27: 1812-1821
2. Codreanu I, Perico N, Sharma SK et al. Prevention programmes of progressive renal disease in developing nations. Nephrology 2006; 11: 321-328
3. Astor BC, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative metaanalysis of kidney disease population cohorts. Kidney Int 2011;79,:1331-1340
4. van der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011; 79: 1341-1352
5. Nugent RA, Fathima SF, Feigl AB et al. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011; 118: C269-CC76
6. James PT, Leach R, Kalamara E et al. The worldwide obesity epidemic. Obesity Res 2001; 9: 228S-233S
7. Swinburn BA, Sacks G, Hall KD et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011; 378: 804-814
8. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117. doi: 10.1186/1471-2458-8-117.
9. Abegunde DO, Mathers CD, Adam T et al. Chronic diseases 1- The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007; 370: 1929-1938
10. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276
11. Couser WG, Remuzzi G, Mendis S et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258-1270
12. Khoury MJ, Gwinn M, Ioannidis JPA. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol 2010; 172: 517-524
13. WH Organization. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases: Prevent and Control Cardiovascular Diseases, Cancers, Chronic Respiratory Diseases and Diabetes. Geneva: World Health Organization, 2008
14. Narayan KM, Gregg EW, Engelgau MM et al. Translation research for chronic disease: the case of diabetes. Diabetes Care 2000; 23: 1794-1798
15. Berkelman RL, Buehler JW. Public health surveillance of non-infectious chronic diseases: the potential to detect rapid changes in disease burden. Int J Epidemiol 1990; 19: 628-635
16. Thacker SB, Stroup DF, Rothenberg RB. Public health surveillance for chronic conditions: a scientific basis for decisions. Stat Med 1995; 14: 629-641
17. Mcclellan WM, Krisher JO. Collecting and using patient and treatment center data to improve care: adequacy of hemodialysis and end-stage renal disease surveillance. Kidney Int 2000; 57: S7-S13
18. Hull A. The 1989 dallas conference on morbidity and mortality in dialysis: what did we learn? Clin J Am Soc Nephrol 2009; 4: S2-S4
19. Jencks SF, Wilensky GR. The health-care quality improvement initiative: a new approach to quality assurance in medicare. JAMA 1992; 268: 900-903
20. Levinsky NG, Rettig RA. The medicare end-stage renal-disease program: a report from the institute-of-medicine. New Engl J Med 1991; 324: 1143-1148
21. McClellan WMH, Helgerson SD, Frederick PR et al. Implementing the health care quality improvement program in the medicare ESRD program: a new era of quality improvement in ESRD. Adv Ren Replace Ther 1995; 2: 89-94
22. Hornberger JC. The hemodialysis prescription and quality-adjusted life expectancy. Renal Physicians Association Working Committee on Clinical Guidelines. J Am Soc Nephrol 1993; 4: 1004-1020
23. Eknoyan G, Levin NW, Eschbach JW et al. Continuous quality improvement: DOQI becomes K/DOQI and is updated. Am J Kidney Dis 2001; 37: 179-180
24. Goldman RS, Latos DL. Dialysis medical directors' role in maintaining quality of care and responsibility for facility-specific patient outcomes: evolution and current status. Semin Dial 2012; 25: 286-290
25. Helgerson SD, McClellan WM, Frederick PR et al. Improvement in adequacy of delivered dialysis for adult in-center hemodialysis patients in the United States, 1993 to 1995. Am J Kidney Dis 1997; 29: 851-861
26. Wolfe RA, Hulbert-Shearon TE, Ashby VB et al. Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis 2005; 45: 127-135
27. NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy, peritoneal dialysis adequacy, vascular access, and anemia of chronic kidney disease: update 2000. Am J Kidney Dis 2001; 37: S7-S238
28. Lynch JR, Wasse H, Armistead NC et al. Achieving the goal of the fistula first breakthrough initiative for prevalent maintenance hemodialysis patients. Am J Kidney Dis 2011; 57: 78-89
29. MacGregor MS, Taal MW. Renal Association Clinical Practice Guideline on detection, monitoring and management of patients with CKD. Nephron Clin Pract 2011; 118(Suppl. 1): c71-c100
30. London TRAatRCoPo. Treatment of adults and children with renal failure: standards and audit measures. 3rd edn. Suffolk: The Lavenham Press, 2002
31. Veterans Health Administration DoD. VHA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease and pre-ESRD in the Primary Care Setting. Washington, DC: Dept of Veterans Affairs (US), Veterans Health Administration, 2001
32. Johnson DW. Prevention of progression of kidney disease: CARI guidelines. Aust Fam Physician 2007; 36: 353
33. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease. Am J Kidney Dis 2002; 39: S1-S266
34. Vassalotti JA. The cycle of development, publication, and implementation of clinical practice guidelines for CKD. Kidney Int 2012; 81: 1159-1161
35. Jadoul M, Wiecek A, Van Biesen W. A decade after the KDOQI CKD guidelines: a perspective from Europe. Am J Kidney Dis 2012; 60: 743-744
36. Barsoum RS. A decade after the KDOQI CKD guidelines: a perspective from Egypt. Am J Kidney Dis 2012; 60: 745-746
37. Abensur H, Yu L, Burdmann EA. A decade after the KDOQI CKD guidelines: a perspective from Brazil. Am J Kidney Dis 2012; 60: 738-739
38. Obrador GT, Paniagua R. A decade after the KDOQI CKD guidelines: a perspective from Mexico. Am J Kidney Dis 2012; 60: 736-737
39. Jafar TH, Agarwal SK. A decade after the KDOQI CKD guidelines: a perspective from South Asia. Am J Kidney Dis 2012; 60: 731-733
40. Jha V. A decade after the KDOQI CKD guidelines: a perspective from India. Am J Kidney Dis 2012; 60: 734-735
41. Imai E, Yasuda Y, Matsuo S. A decade after the KDOQI CKD guidelines: a perspective from Japan. Am J Kidney Dis 2012; 60: 729-730
42. Wang H, Zhang L, Zuo L. A decade after the KDOQI CKD guidelines: a perspective from China. Am J Kidney Dis 2012; 60: 727-728
43. Polkinghorne KR, Chadban SJ. A decade after the KDOQI CKD guidelines: a perspective from Australia. Am J Kidney Dis 2012; 60: 725-726
44. Hemmelgarn BR, Manns BJ, Tonelli M. A decade after the KDOQI CKD guidelines: a perspective from Canada. Am J Kidney Dis 2012; 60: 723-724
45. Alwan A, MacLean DR, Riley LM et al. Chronic diseases: chronic diseases and development 5 monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010; 376: 1861-1868
46. Saran R, Hedgeman E, Plantinga L et al. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol 2010; 5: 152-161
47. Kleophas W, Bieber B, Robinson BM et al. Implementation and first results of a German Chronic Kidney Disease Registry. Clin Nephrol 2012; in press.
48. Eckardt KU, Barthlein B, Baid-Agrawal S et al. The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transplant 2012; 27: 1454-1460
49. Garcia MG, Mujica MPV, Ocana JCM et al. Results of a coordination programme and shared clinical information between primary care and nephrology. Nefrologia 2011; 31: 84-90
50. Hemmelgarn BR, Manns BJ, Straus S et al. Knowledge translation for nephrologists: strategies for improving the identification of patients with proteinuria. J Nephrol 2012; 25: 933-943
51. Tsukamoto Y. Implication of global nephrology guidelines in Asia and 'Asian CKD Best Practice Guidelines'. Nephrology 2010; 15: 43-44
52. Quintaliani G, Cappelli G, Lodetti L et al. Chronic kidney disease certification process manual by the Italian Society of Nephrology (SIN): part 2: programme management and clinical information management. J Nephrol 2009; 22: 565-570
53. O'Donoghue DJ, Stevens PE. A decade after the KDOQI CKD/ guidelines: a perspective from the United Kingdom. Am J Kidney Dis 2012; 60: 740-742
54. Ibrahim HN, Weber ML. Weight loss: a neglected intervention in the management of chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 534-538
55. Navaneethan SD, Yehnert H, Moustarah F et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4: 1565-1574
56. Afshinnia F, Wilt TJ, Duval S et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010; 25: 1173-1183
57. Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nature Rev Nephrol 2012; 8: 301-306
58. Mohsen A, Brown R, Hoefield R et al. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus. J Nephrol 2012; 25: 384-393
59. Brown R, Mohsen A, Green D et al. Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects. Nephrol Dial Transplant 2012; 27: 2776-2780
60. Khedr A, Khedr E, House AA. Body mass index and the risk of progression of chronic kidney disease. J Renal Nutr 2011; 21: 455-461
61. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 2007; 49: 581-591
62. Kalantar-Zadeh K. What is so bad about reverse epidemiology anyway? Semin Dial 2007; 20: 593-601
63. Florez H, Castillo-Florez S. Beyond the obesity paradox in diabetesfitness, fatness, and mortality. JAMA 2012; 308: 619-620
64. Flegal KM, Kit BK, Orpana H et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71-82
65. Foster MC, Hwang SJ, Larson MG et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008; 52: 39-48
66. Kalantar-Zadeh K, Streja E, Molnar MZ et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 2012; 175: 793-803
67. Kramer H, Shoham D, McClure LA et al. Association of waist circumference and body mass index with all-cause mortality in CKD: the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 2011; 58: 177-185
68. Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 2011; 305: 822-823